Reporting perioperative complications of radical cystectomy: the influence of using standard methodology based on ICARUS and EAU quality criteria
暂无分享,去创建一个
[1] S. Shariat,et al. Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy. , 2022, Urologic oncology.
[2] F. Montorsi,et al. Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy , 2022, World Journal of Urology.
[3] Lili Mi,et al. Prognosis of hepatocellular carcinoma and its association with immune cells using systemic inflammatory response index. , 2022, Future oncology.
[4] M. Michalak,et al. Neutrophil Counts, Neutrophil-to-Lymphocyte Ratio, and Systemic Inflammatory Response Index (SIRI) Predict Mortality after Off-Pump Coronary Artery Bypass Surgery , 2022, Cells.
[5] Cong Jiang,et al. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. , 2022, Clinical breast cancer.
[6] F. Saad,et al. Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy , 2022, Cancers.
[7] J. B. Jensen,et al. Prospective versus retrospective recordings of comorbidities and complications in bladder cancer patients undergoing radical cystectomy – a randomized controlled trial , 2021, Scandinavian journal of urology.
[8] Tianyuan Xu,et al. Combination of Total Psoas Index and Albumin–Globulin Score for the Prognosis Prediction of Bladder Cancer Patients After Radical Cystectomy: A Population-Based Study , 2021, Frontiers in Oncology.
[9] C. Liang,et al. Prognostic Value of the Systemic Inflammatory Response Index in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study , 2021, Frontiers in Oncology.
[10] Jarosław Jaskulski,et al. The Comprehensive Complication Index. Proposed modification to improve estimates of perioperative morbidity after radical cystectomy. A pilot study , 2021, Central European journal of urology.
[11] Dong-lin Hao,et al. Systemic inflammatory response index as an independent risk factor for ischemic stroke in patients with rheumatoid arthritis: a retrospective study based on propensity score matching , 2021, Clinical Rheumatology.
[12] Yonghua Lei,et al. Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle- invasive bladder cancer undergoing radical cystectomy. , 2021, Archivos espanoles de urologia.
[13] H. Kehlet,et al. Short-term morbidity and mortality following radical cystectomy: a systematic review , 2021, BMJ Open.
[14] Yong-Beom Park,et al. Systemic inflammation response index predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis , 2021, International Urology and Nephrology.
[15] J. Breyer,et al. The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[16] M. Walach,et al. The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery , 2020, World Journal of Urology.
[17] L. Mordasini,et al. The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature , 2020, World Journal of Urology.
[18] J. Witjes,et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. , 2020, European urology.
[19] J. Witjes,et al. The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel. , 2019, European urology oncology.
[20] J. Pečánka,et al. Intraoperative Adverse Incident Classification (EAUiaiC) by the European Association of Urology ad hoc Complications Guidelines Panel. , 2019, European urology.
[21] P. Malmström,et al. No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study , 2019, World Journal of Urology.
[22] Xiaozhou He,et al. Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis , 2019, Cancer management and research.
[23] Xiaoping Zhou,et al. Pre-treatment prognostic nutritional index may serve as a potential biomarker in urinary cancers: a systematic review and meta-analysis , 2018, Cancer Cell International.
[24] Tetsuya Shindo,et al. Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan , 2018, International Journal of Clinical Oncology.
[25] K. Hirakawa,et al. The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study , 2017, BMC Cancer.
[26] Hong-zhao Li,et al. Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model , 2016, Oncotarget.
[27] Zhen Chen,et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy , 2016, Cancer.
[28] F. Montorsi,et al. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study. , 2014, European urology.
[29] E. Wallen,et al. Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity , 2014, BJU international.
[30] Will Liao,et al. The cellular and molecular origin of tumor-associated macrophages , 2014, Science.
[31] M. Remzi,et al. Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. , 2012, European urology.
[32] A. Vickers,et al. Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer , 2008, Cancer.
[33] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[34] M. Srougi,et al. Complications in radical cystectomy performed at a teaching hospital. , 2002, International braz j urol : official journal of the Brazilian Society of Urology.
[35] Robert C. G. Martin,et al. Quality of Complication Reporting in the Surgical Literature , 2002, Annals of surgery.
[36] Steven A. Rosenberg,et al. Progress in human tumour immunology and immunotherapy , 2001, Nature.
[37] P. Gild,et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. , 2019, European urology.
[38] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..